Methods The original version of this document was developed in consultation with the
International Forum for Acute Care Trialists (InFACT), International Severe Acute Respiratory …

2019 (COVID-19) is either indirect (from studies of influenza, severe acute respiratory
syndrome and Middle East respiratory syndrome) or from several observational studies and …

Background Coronavirus disease 2019 (COVID-19) is a disease caused by severe acute
respiratory syndrome-coronavirus-2. Consensus suggestions can standardise care, thereby …

COVID‐19: Interim Guidance on Management Pending Empirical Evidence. From an American
Thoracic Society‐led Int Page 1 1 Updated April 3, 2020 COVID‐19: Interim Guidance on …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus
disease 2019 (COVID-19), has spread across the globe resulting in a pandemic. At the time …

Since the identification of SARS-CoV-2 at the end of 2019, the coronavirus disease 2019
(COVID-19) pandemic has affected more than 410 million people worldwide and killed …

Background There are many pharmacologic therapies that are being used or considered for
treatment of coronavirus disease 2019 (COVID-19). There is a need for frequently updated …

ABSTRACT The COVID-19 Treatment Guidelines were developed to provide clinicians with
guidance on caring for patients with COVID-19. Because clinical information about the …

Abstract Scope In January 2021, the ESCMID Executive Committee decided to launch a new
initiative to develop ESCMID guidelines on several COVID-19-related issues, including …

BACKGROUND: The coronavirus disease 2019 pandemic continues to affect millions
worldwide. Given the rapidly growing evidence base, we implemented a living guideline …